New Zealand
helps discover gene.
Special
Education 2000.
NEW ZEALAND SCIENTIST HELPS DISCOVER TUMOUR GENE
New Zealander Dr Russell Snell leads a genetic research team in Cardiff, Wales, which is part of an international collaboration that recently isolated the gene responsible for Tuberous Sclerosis, a rare and inherited condition involving multiple tumours. The paper explaining the discovery has just been published in the prestigious international scientific journal Science.
Tuberous Sclerosis affects approximately one in 6,000 newborns.
People with the condition can develop tumours in the brain, skin, heart, lungs and kidneys, with different sumptoms appearing at different stages of life. Few of the tumours are malignant, and for some people the only signs may be de-pigmented skin lesions and small tuber-like skin growths. But Tuberous Sclerosis can also be devastating. Heart tumours in babies and brain or kidney tumours in adulthood can be fatal. Brain tumours also often cause mental disabilities, epilepsy, autism or attention deficity-hyperactive disorder.
The newly-identified gene is thought to be a tumour suppressor, which normally operates by controlling cell growth. The collaboration discovered 30 different mutations in the gene, which stop its normal action and allow tumours to develop.
Dr Snell is "very excited" about the discovery. "It will enable a better diagnosis for patients and members of families affected by the condition," he says. "Clearly the long term aim is to develop a treatment for Tuberous Sclerosis. Another exciting prospect is that genes like this are often involved in cancers, so this may shed light on the cancer process in general."
Pat Coakley, of the NZ Tuberous Sclerosis Support Group, says the finding gives families affected by the condition more hope for the future. Families could soon be tested with a simple blood test.
Dr Snell's Cardiff work is partly funded by the Health Research Council. He will return to the University of Auckland in January 1998 to work with Professor Richard Faull on a transgenic model for Huntington's disease, which will hopefully lead to treatments for the condition. Dr Snell has previously worked on transgenic mice at Ruakura, and during his PhD in genetics at Cardiff was involved in the isolation of the gene for Huntington's Disease and discovery of the gene for Myotonic Dystrophy. Information Dr Russell Snell, e-mail SnellRG@cardiff.ac.uk, phone
Mr Pat Coakley, NZ Tuberous Sclerosis Support Group, phone 09 483 5392,
e-mail PatCoakley@lion-nathan.co.nz
On the significance of the discovery - Dr Don Love, University of Auckland School of Biological Sciences, phone 09 373 7599 ex 7228 (available from Monday, August 18)
Special Education 2000-what on earth is happening?
What are the issues?
There appear to be three main problem areas:
What can be done?
How much is enough?
SE2000 promises an increase in support for students with high and very high needs who are eligible for Ongoing Resourcing Scheme, from part way through next year. The support will be teacher aide hours at this stage.
So for students what sort of support will be needed?
It is hard to imagine that a student who meets the "very high" criteria and is in a regular class would need anything less than full time support, as well as specialist teacher time and other interventions. The teacher aide component would cost a minimum of $10 000.
For a student with high needs, we could guess that about 15-20 hours support per week would be needed. This would cost at least $6 000.
If this policy is to work, it must be funded adequately. We are watching this aspect of the policy very carefully, and will let you know the details when they are received.
Fund holding.
A new development in SE2000 is the idea of schools or clusters of schools being able to manage the funds for their students in the Ongoing Resourcing Scheme.
We believe there is not enough information for schools to make decisions on, and there has been no consultation with parents.
Questions, questions.
Here are some questions that need to be answered. How about asking them locally. Let us have a copy of any answers you receive.
? There will be far fewer students receiving ORS funding than previously got SEDA so how will the extra $17 million promised for 1998 be used?
? How will schools be accredited to be fund holders? Will parents be consulted?
? What rights will parents have to appeal ORS decisions, and decisions made by schools?
? Exactly what sort of "further information" will be gathered before ORS is fully implemented? Will parents be consulted?
? How will decisions be made about funding in different school settings? (eg: special, regular) Will parents be consulted?
? How will the Nelson trial of full special education funding be monitored? Will parents be consulted? Will their opinions be given the same weight as schools?
Criteria for the Ongoing Resourcing Scheme. Students with very high needs are expected to have ongoing needs throughout their school years because of one or more of the following:
Students with high needs are expected to have ongoing needs throughout their school years because of one or more of the following:
Ministry for Education. Letter to school principals, 14 November 1997. |
Contact details: IHC Advocacy Centre Staff in Wellington 04 472 2247 or 0800IHCIHC; in Auckland Sue McKinnon 09 379 5760.